Setting bioequivalence requirements for drug development based on preclinical data: Optimizing oral drug delivery systems

Journal of Controlled Release

Volumn 62, Issue 1-2, 1999, Pages 41-49

  Lipka, E ^a   Amidon, G L ^b  

^a TSRL INC   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Biopharmaceutics Classification System; Dissolution; Optimized drug delivery systems; Permeability; PK PD Correlation

Indexed keywords

ARTICLE; BIOEQUIVALENCE; DRUG ABSORPTION; DRUG APPROVAL; DRUG CLASSIFICATION; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; MEMBRANE PERMEABILITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

NON-PROGRAMMATIC;

ADMINISTRATION, ORAL; DATABASES, FACTUAL; DOSAGE FORMS; DRUG DELIVERY SYSTEMS; DRUG EVALUATION; HUMANS; INTESTINAL ABSORPTION; PERMEABILITY; PHARMACEUTICAL PREPARATIONS; SOLUBILITY; THERAPEUTIC EQUIVALENCY;

EID: 0032844618     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(99)00022-X     Document Type: Article

References (22)

1. Amidon G.L., Lennernas H., Shah V.P., Crison J.R. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12:1995;413-420.
2. Amidon G.L. A biopharmaceutic classification system: update May 1996, the rationale for a biopharmaceutics drug classification. Capsugel Seminar and Open Forum :1996;9 Capsugel Symposia Series, Geneva.
3. Amidon G.L., Robinson J.R., Williams R.L. Scientific Foundations For Regulating Drug Product Quality. 1997;AAPS Press, Alexandria, VA.
4. Oh D-M., Curl R.L., Amidon G.L. Estimating the fraction dose absorbed from suspensions of poorly soluble compounds in humans: a mathematic model. Pharm. Res. 10:1993;264-268.
5. Crison J.R., Shah V.P., Skelly J.P., Amidon G.L. Drug dissolution into micellar solutions: development of a convective diffusion model and comparison to the film equilibrium model with application to surfactant-facilitated dissolution of carbamazepine. J. Pharm. Sci. 85:1996;1005-1011.
6. Lennernas H., Ahrenstedt O., Hallgren R., Knutson L., Ryde M., Paalzow L.K. Regional jejunal perfusion, a new in vivo approach to study oral drug absorption in man. Pharm. Res. 9:1992;1243-1251.
7. Dressman J.B., Amidon G.L., Reppas C., Shah V.P. Dissolution testing as a prognostic tool for oral drug absorption: Immediate release dosage forms. Pharm. Res. 15:(1):1998;11-22.
8. Lennernas H., Ahrenstedt O., Ungell A. Intestinal drug absorption during induced net water absorption in man; a mechanistic study using antipyrine, atenolol and enlaprilat. Br. J. Clin. Parmacol. 37:1994;589-596.
9. Nilsson D., Fagerholm U., Lennernas H. The influence of net water absorption on the permeability of antipyrine and levodopa in the human jejunum. Pharm. Res. 11:(11):1994;1540-1547.
10. Fagerholm U., Borgstrom L., Ahrenstedt O., Lennernas H. The lack of effect of induced net fluid absorption on the in vivo permeability of terbutaline in the human jejunum. J. Drug Target. 3:(3):1995;191-200.
11. Takamatsu N., Welage L.S., Idkaidek N.M., Liu D.Y., Lee I., Lennernas H., Barnett J., Shah V., Lesko L., Amidon G.L. Human intestinal permeability of piroxicam, propranolol, phenylalanine and PEG 400 determined by jejunal perfusion. Pharm. Res. 14:(9):1997;1127-1132.
12. Walter E., Janich S., Roessler B.J., Hilfinger J.M., Amidon G.L. HT-29-MTX/Caco-2 Cocultures as an in vitro model for the intestinal epithelium: In vitro/in vivo correlation with permeability data from rats and humans. J. Pharm. Sci. 85:(10):1996;1070-1076.
13. Kararli T.T. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm. Drug Disp. 16:1995;351-380.
14. Davis B., Morris T. Physiological parameters in laboratory animals. Pharm. Res. 10:1993;1093-1095.
15. Yu L.X., Lipka E., Crison J.R., Amidon G.L. Transport approaches to the biopharmaceutical design of oral drug delivery systems: prediction of intestinal absorption. Advan. Drug Deliv. Rev. 19:1996;359-376.
16. Lipka E., Yu L., Liu D., Crison J.R., Amidon G.L. Evaluation of the intestinal permeabilities of β-blocker drugs and their potential for oral controlled release. Proc. Intern. Symp. Control. Rel. Bioact. Mater. 22:1995;366.
17. Smolensky M.H., D'Alonzo G.E. Biological rhythms and medicine. Am. J. Med. 85:1988;34-46.
18. Dethlefsen U., Repges R. Ein neues Therapieprinzip bei naechtlichem Asthma. Med. Klin. 80:1985;44.
19. Moore J.G., Englert E. Circadian rhythm of gastric acid secretion in man. Nature. 226:1970;1261.
20. Solomon G.D. Circadian rhythms and migraine. Cleveland Clin. J. of Med. 59:(3):1992;326-329.
21. Lemmer B. Chronopharmacology - Cellular and Biochemical Interactions. 1989;Marcel Dekker, New York, Basel.
22. Lemmer B. Circadian rhythms and drug delivery. J. Control. Rel. 16:1991;63-74.